RapidAI is the trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. Used by more than 2,500 hospitals in over 100 countries and backed by 700+ clinical studies, RapidAI's technology has been instrumental in expanding national stroke-treatment guidelines from 6 to 24 hours - directly saving lives that would otherwise be lost. The Rapid Enterprise™ Platform supports disease states across the care spectrum, but it's the company's clinical depth that drives the most meaningful impact, improving decision-making, patient outcomes, and health-system performance.
Rooted in clinical validation and fueled by curiosity, RapidAI innovates with purpose - delivering AI-powered medical imaging and care coordination solutions that transform how healthcare teams respond to life-threatening neurovascular and vascular conditions. From stroke to aneurysm, pulmonary embolism to aortic disease, RapidAI's technology gives clinicians the tools they need to identify treatment candidates faster, coordinate care more effectively, and ultimately save more lives when every second matters. This is AI beyond the algorithm.
